Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 1.41% | |
| Drug Manufacturers - General | 33.77% | 0.37% | |
| Medical Devices | 13.11% | 1.77% | |
| Healthcare Plans | 12.36% | 2.94% | |
| Diagnostics & Research | 11.27% | 3.09% | |
| Biotechnology | 10.82% | -1.05% | |
| Medical Instruments & Supplies | 8.10% | 2.41% | |
| Medical Care Facilities | 2.86% | 0.87% | |
| Drug Manufacturers - Specialty & Generic | 2.67% | 0.86% | |
| Medical Distribution | 2.54% | 3.09% | |
| Health Information Services | 2.33% | 5.10% | |
| Pharmaceutical Retailers | 0.16% | 24.69% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| | 999.43 | 11.39% | | | | Buy | |
| | 625.10 | 7.59% | | | | Buy | |
| | 175.98 | 5.42% | | | | Buy | |
| | 208.90 | 4.90% | | | | Buy | |
| | 133.43 | 3.98% | | | | Buy | |
| | 657.43 | 3.29% | | | | Buy | |
| | 539.24 | 3.09% | | | | Buy | |
| | 130.24 | 3.09% | | | | Buy | |
| | 288.34 | 2.69% | | | | Buy | |
| | 32.62 | 2.40% | | | | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 36.396B | 0.09% | | |
| | 18.975B | 0.10% | | |
| | 6.463B | 0.45% | | |
| | 6.369B | 0.35% | | |
| | 4.4B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| | 40.511B | 0.30% | | |
| | 40.511B | 0.30% | | |
| | 18.975B | 0.10% | | |
| | 13.014B | 0.80% | | |
| | 13.014B | 0.80% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Tilray Brands, Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
RatingPrice TargetMorningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, some unique opportunities in generics; how Facebook's move should not move eBay's positioning; and California wildfires' impact on P&C insurers; and Walgreens Boots Alliance, Sodexo, and STMicroelectronics
Analyst Report: Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
RatingPrice TargetAnalyst Report: Curaleaf Holdings, Inc.
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
RatingPrice Target
